You just read:

Trial Data Demonstrates Bard LIFESTENT® Vascular Stent Is Superior to Angioplasty for Lesions in Superficial Femoral Artery and Proximal Popliteal Artery

News provided by

C.R. Bard, Inc.

Jun 16, 2010, 15:29 ET